v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
To Be Issued
Additional Paid-in Capital
Accumulated Deficit
Non- controlling Interest
Total
Balance at Dec. 31, 2024 $ 5,154 $ 265 $ 25,607,397 $ (26,312,700) $ (351,402) $ (1,051,286)
Balance (in Shares) at Dec. 31, 2024 51,538,193 2,657,550        
Vesting of compensatory warrants 69,586 69,586
Common stock sold for cash $ 25 249,975 250,000
Common stock sold for cash (in Shares) 250,000        
Common stock issued to directors for conversion of fees $ 15 149,985 150,000
Common stock issued to directors for conversion of fees (Shares) 150,000        
Common stock issued to officers for conversion of salaries $ 18 179,982 180,000
Common stock issued to officers for conversion of salaries (Shares) 180,000        
Common Stock Issued For Conversion of Note Payable $ 25 249,975 250,000
Common Stock Issued For Conversion Of Note Payable (in share) 250,000        
Imputed interest on related party loans 14,548 14,548
Derecognition of noncontrolling interest 351,402 351,402
Net income (loss) (789,596) (789,596)
Balance at Jun. 30, 2025 $ 5,237 $ 265 26,521,448 (27,102,296) (575,346)
Balance (in Shares) at Jun. 30, 2025 52,368,193 2,657,550        
Balance at Dec. 31, 2024 $ 5,154 $ 265 25,607,397 (26,312,700) (351,402) (1,051,286)
Balance (in Shares) at Dec. 31, 2024 51,538,193 2,657,550        
Balance at Dec. 31, 2025 $ 5,690 28,465,847 (29,017,305) (545,768)
Balance (in Shares) at Dec. 31, 2025 56,900,743        
Balance at Mar. 31, 2025 $ 5,160 $ 265 25,709,581 (26,874,573) (1,159,567)
Balance (in Shares) at Mar. 31, 2025 51,598,193 2,657,550        
Vesting of compensatory warrants 34,793 34,793
Common stock sold for cash $ 19 189,981 190,000
Common stock sold for cash (in Shares) 190,000        
Common stock issued to directors for conversion of fees $ 15 149,985 150,000
Common stock issued to directors for conversion of fees (Shares) 150,000        
Common stock issued to officers for conversion of salaries $ 18 179,982 180,000
Common stock issued to officers for conversion of salaries (Shares) 180,000        
Common Stock Issued For Conversion of Note Payable $ 25 249,975 250,000
Common Stock Issued For Conversion Of Note Payable (in share) 250,000        
Imputed interest on related party loans 7,151 7,151
Net income (loss) (227,723) (227,723)
Balance at Jun. 30, 2025 $ 5,237 $ 265 26,521,448 (27,102,296) (575,346)
Balance (in Shares) at Jun. 30, 2025 52,368,193 2,657,550        
Balance at Dec. 31, 2025 $ 5,690 28,465,847 (29,017,305) (545,768)
Balance (in Shares) at Dec. 31, 2025 56,900,743        
Vesting of Stock Options 14,180 14,180
Common stock sold for cash $ 143 2,863,607 2,863,750
Common stock sold for cash (in Shares) 1,431,875        
Common stock issued to directors for conversion of fees $ 3 56,247 56,250
Common stock issued to directors for conversion of fees (Shares) 28,125        
Common stock issued upon consummation of acquisition $ 420 8,399,580 8,400,000
Common stock issued upon consummation of acquisition (in Shares) 4,200,000        
Common stock issued to officers for conversion of salaries          
Net income (loss) 15,936,368 15,936,368
Balance at Jun. 30, 2026 $ 6,256 39,799,461 (13,080,937) $ 26,724,780
Balance (in Shares) at Jun. 30, 2026 62,560,743       2,657,550
Balance at Mar. 31, 2026 $ 6,185 38,365,352 (29,352,693) $ 9,018,844
Balance (in Shares) at Mar. 31, 2026 61,850,743        
Vesting of Stock Options 14,180 14,180
Common stock sold for cash $ 71 1,419,929 1,420,000
Common stock sold for cash (in Shares) 710,000        
Net income (loss) 16,271,756 16,271,756
Balance at Jun. 30, 2026 $ 6,256 $ 39,799,461 $ (13,080,937) $ 26,724,780
Balance (in Shares) at Jun. 30, 2026 62,560,743       2,657,550